Pharmacist CE Sterile Compounding USP 797
31 flashcards covering Pharmacist CE Sterile Compounding USP 797 for the HEALTHCARE-CE Pharmacist CE section.
Sterile compounding is a critical area of pharmacy practice governed by the United States Pharmacopeia (USP) Chapter 797. This regulation outlines the standards for preparing compounded sterile preparations (CSPs) to ensure patient safety and product quality. Compliance with USP 797 is essential for pharmacists, as it addresses aspects such as aseptic technique, environmental controls, and personnel training, all of which are vital for reducing the risk of contamination.
In practice exams and competency assessments, questions on USP 797 typically focus on the principles of sterile compounding, including risk levels of CSPs, appropriate use of personal protective equipment, and the significance of maintaining a sterile environment. A common pitfall for test-takers is misinterpreting the risk levels associated with different compounding scenarios, which can lead to incorrect answers regarding required procedures and precautions.
One important tip to remember is to always double-check the compatibility of ingredients and the expiration dates of compounded preparations, as overlooking these details can compromise patient safety.
Terms (31)
- 01
What is the primary purpose of USP 797 guidelines?
The primary purpose of USP 797 guidelines is to ensure the sterile compounding of medications to prevent harm to patients from microbial contamination, excessive endotoxins, and incorrect strength or ingredients (ACPE / NABP topic outlines for pharmacist CE).
- 02
What is the required air quality classification for sterile compounding areas?
Sterile compounding areas must meet ISO Class 5 air quality standards to minimize the risk of contamination (ACPE / NABP topic outlines for pharmacist CE).
- 03
Under USP 797, what is required for personnel involved in sterile compounding?
Personnel involved in sterile compounding must undergo initial and ongoing training, including competency assessments, to ensure they can perform sterile techniques safely (ACPE / NABP topic outlines for pharmacist CE).
- 04
What is the maximum time allowed for a compounded sterile preparation to remain at room temperature?
Compounded sterile preparations must be used or stored at room temperature for no longer than 24 hours unless otherwise specified (ACPE / NABP topic outlines for pharmacist CE).
- 05
When must a compounding facility undergo a risk assessment according to USP 797?
A compounding facility must undergo a risk assessment whenever there are changes in the compounding process, equipment, or personnel (ACPE / NABP topic outlines for pharmacist CE).
- 06
What is the required frequency for cleaning and disinfecting the compounding area?
The compounding area must be cleaned and disinfected before each shift, before each batch, and after spills (ACPE / NABP topic outlines for pharmacist CE).
- 07
What type of training is required for pharmacy staff involved in sterile compounding?
Pharmacy staff involved in sterile compounding must receive training on aseptic techniques and must demonstrate competency through evaluations (ACPE / NABP topic outlines for pharmacist CE).
- 08
What is the recommended practice for hand hygiene before sterile compounding?
Hand hygiene must include washing hands with soap and water followed by the use of an alcohol-based hand rub before entering the compounding area (ACPE / NABP topic outlines for pharmacist CE).
- 09
What is the role of the cleanroom in sterile compounding?
The cleanroom provides a controlled environment that minimizes contamination risk during the preparation of sterile products (ACPE / NABP topic outlines for pharmacist CE).
- 10
How should hazardous drugs be handled in a sterile compounding environment?
Hazardous drugs must be compounded in a designated area with appropriate engineering controls, such as a Class II biological safety cabinet (ACPE / NABP topic outlines for pharmacist CE).
- 11
What is the appropriate response if a sterile compounding technician is exposed to a hazardous drug?
The technician should immediately follow the facility's exposure protocol, which typically includes decontamination and reporting the incident (ACPE / NABP topic outlines for pharmacist CE).
- 12
What is the purpose of using a laminar flow hood in sterile compounding?
A laminar flow hood provides a sterile environment by directing HEPA-filtered air over the compounding area to minimize contamination (ACPE / NABP topic outlines for pharmacist CE).
- 13
What documentation is required for compounded sterile preparations?
Documentation must include the formulation record, compounding log, and any quality control measures taken (ACPE / NABP topic outlines for pharmacist CE).
- 14
What is the significance of the beyond-use date (BUD) in sterile compounding?
The beyond-use date indicates the time period after which a compounded preparation should not be used to ensure patient safety (ACPE / NABP topic outlines for pharmacist CE).
- 15
How should sterile compounding areas be ventilated?
Sterile compounding areas should be ventilated to maintain ISO Class 5 conditions, ensuring proper airflow and reducing contamination risk (ACPE / NABP topic outlines for pharmacist CE).
- 16
What is the minimum required training for pharmacy technicians involved in sterile compounding?
Pharmacy technicians must complete training in sterile compounding techniques and pass competency assessments before compounding sterile products (ACPE / NABP topic outlines for pharmacist CE).
- 17
What is the preferred method for cleaning surfaces in a sterile compounding area?
Surfaces should be cleaned using a two-step process: first with a detergent followed by a disinfectant effective against microbial contamination (ACPE / NABP topic outlines for pharmacist CE).
- 18
Under USP 797, what is required for the disposal of hazardous waste?
Hazardous waste must be disposed of according to federal, state, and local regulations, ensuring safety and compliance (ACPE / NABP topic outlines for pharmacist CE).
- 19
What is the purpose of an air quality monitoring program in sterile compounding?
An air quality monitoring program ensures that the compounding environment meets required standards and identifies potential contamination issues (ACPE / NABP topic outlines for pharmacist CE).
- 20
What is the recommended practice for gowning before entering a sterile compounding area?
Personnel must don sterile gowns, gloves, masks, and hair covers to minimize contamination risk before entering the sterile compounding area (ACPE / NABP topic outlines for pharmacist CE).
- 21
What is the required action if a sterile compounding area fails air quality testing?
If a sterile compounding area fails air quality testing, it must be investigated, cleaned, and retested before compounding can resume (ACPE / NABP topic outlines for pharmacist CE).
- 22
What is the role of a designated person in sterile compounding?
A designated person is responsible for ensuring compliance with USP 797 standards and overseeing the sterile compounding process (ACPE / NABP topic outlines for pharmacist CE).
- 23
What is the significance of using aseptic technique in sterile compounding?
Aseptic technique is critical in sterile compounding to prevent contamination and ensure the safety and efficacy of compounded medications (ACPE / NABP topic outlines for pharmacist CE).
- 24
What is required for the validation of compounding processes according to USP 797?
Validation of compounding processes must demonstrate that the process consistently produces a product that meets quality standards (ACPE / NABP topic outlines for pharmacist CE).
- 25
How often should personnel perform hand hygiene in a sterile compounding area?
Personnel must perform hand hygiene before entering the compounding area and regularly throughout the compounding process (ACPE / NABP topic outlines for pharmacist CE).
- 26
What is the purpose of environmental monitoring in sterile compounding?
Environmental monitoring aims to detect and control potential sources of contamination in the compounding area (ACPE / NABP topic outlines for pharmacist CE).
- 27
What is the role of quality assurance in sterile compounding?
Quality assurance ensures that all compounding processes meet established standards and that products are safe for patient use (ACPE / NABP topic outlines for pharmacist CE).
- 28
What is the appropriate response if a compounded sterile preparation is found to be contaminated?
The contaminated preparation must be quarantined, documented, and disposed of according to facility protocols (ACPE / NABP topic outlines for pharmacist CE).
- 29
What is the purpose of using personal protective equipment (PPE) in sterile compounding?
PPE protects personnel from exposure to hazardous substances and minimizes the risk of contamination during the compounding process (ACPE / NABP topic outlines for pharmacist CE).
- 30
How should compounded sterile preparations be labeled?
Compounded sterile preparations must be labeled with the name of the preparation, strength, quantity, BUD, and storage instructions (ACPE / NABP topic outlines for pharmacist CE).
- 31
What is the maximum time frame for completing a sterile compounding process?
The entire sterile compounding process should be completed in a timely manner to minimize the risk of contamination, ideally within the same day (ACPE / NABP topic outlines for pharmacist CE).